Joel Greenblatt’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,412
Closed -$208K – 1925
2026
Q2
$208K Buy
+4,412
New +$109K ﹤0.01% 1728
2026
Q1
– Sell
-17,825
Closed -$239K – 1825
2025
Q4
$239K Buy
17,825
+823
+5% +$10.2K ﹤0.01% 1626
2025
Q3
$200K Buy
17,002
+2,924
+21% +$27.3K ﹤0.01% 1616
2025
Q2
$91.4K Buy
+14,078
New +$92.6K ﹤0.01% 1620

Other funds holding DFTX

Joel Greenblatt's DFTX Position: Q3 2026 in Review

Joel Greenblatt sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 4,412 shares — an estimated $208K sold.

Joel Greenblatt first reported a position in DFTX in Q2 2025 and held it in 4 quarters. The position peaked at $239K in Q4 2025. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Joel Greenblatt reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 4,412 Definium Therapeutics shares in Q3 2026, an estimated $208K.
  • Joel Greenblatt first reported a position in Definium Therapeutics in Q2 2025 and held it in 4 quarters.
  • Joel Greenblatt's Definium Therapeutics position peaked at $239K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.